The diagnosis of SSc-ILD is based on finding ILD on the HRCT of the chest in a patient with known SSc, and with exclusion of other etiologies of pulmonary parenchymal disease such as …

Systemic sclerosis (SSc; scleroderma) has the highest individual mortality of all rheumatic diseases and interstitial lung disease (ILD) is among the leading causes of SSc-related death.

Scleroderma-associated interstitial lung disease, or “SSc-ILD”, is a chronic lung disease in which scar tissue (“fibrosis”) and/or inflammation builds up in the walls of the air sacs of the lungs in …

2019年1月18日 · In this article, we provide an overview of the identification, assessment, clinical course and management of SSc-ILD, including therapies under investigation. In 2013, ACR …

Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) that is often progressive and has a poor prognosis [1-7]. SSc-associated ILD consists of various …

2023年5月15日 · Interstitial lung disease associated with systemic sclerosis (SSc-ILD) is one of the important pulmonary manifestations of systemic sclerosis. It usually gives a NSIP type …

2023年1月9日 · Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for …

2019年1月18日 · ILD can develop in any patient with SSc, including those with pulmonary hypertension, but the risk is increased in those with diffuse (rather than limited) cutaneous …

2024年1月15日 · Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in patients with systemic sclerosis (SSc). To date, clinical practice guidelines …

SSc-ILD is known to be more common among patients who have anti-topoisomerase antibodies than in patients without, and it is relatively rare among people with anti-centromere …